Multiple Therapies according to biomarker status in patients with Lung Cancer

A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, with locally advanced, unresectable, Stage III Non-Small Cell Lung Cancer

Disease Types: Lung

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, with locally advanced, unresectable, Stage III Non-Small Cell Lung Cancer

For More Information:

https://clinicaltrials.gov/ct2/show/NCT05170204?term=A+Phase+I-III%2C+Multicenter+Study+Evaluating+the+Efficacy+and+Safety+of+Multiple+Therapies+in+Cohorts+of+Patients+Selected+According+to+Biomarker+Status%2C+with+locally+advanced%2C+unresectable%2C+Stage+III+Non-Small+Cell+Lung+Cancer&draw=2&rank=1